ESPN college basketball analyst Dick Vitale says he is cancer free after battling four different types of the disease over ...
Hall of Fame broadcaster Dick Vitale revealed Wednesday that he remains cancer free following a recent PET scan. The longtime ...
Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer ...
“We have funding, fully funded through donations, for a PET/CT, that we have on the table, and we have to the tune of $18 to $20 million for a cath lab to be at Royal Inland Hospital hospital,” ...
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and ...
She has helped robots learn to get around indoors and pick up balls from the ground. And she has developed computer programs ...
MedPage Today on MSN
Practice-Influencing Results in Oligometastatic Prostate Cancer
Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...
Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company ...
The Nation UAE on MSN
Pakistan Atomic Energy Commission’s Cancer Hospital Organizes World Radiotherapy Awareness Day
The Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), a leading cancer hospital of the Pakistan Atomic Energy ...
News-Medical.Net on MSN
Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results